Numbing Creams for Ejaculation Control, and Whether They Are Worth Using

No anaesthetic cream is licensed in the UK for premature ejaculation. The licensed topical route is a cutaneous spray, and it is prescription-only.

That is the short answer. The longer one is more useful, because the question people are really asking is whether using a cream anyway is reasonable. This page answers that with the actual warnings from licensed product information rather than with a shrug.

Some of those warnings are specific and easy to trigger. Absorption increases on newly shaven skin. Creams should not go on broken skin. Prilocaine carries a named blood disorder risk in certain people. Contact with the eye can cause chemical burns. None of that appears in a product review.

Tattoo numbing cream is the version of this idea most likely to cause harm, so it gets its own section.

Key things to know

• No anaesthetic cream holds a UK licence for premature ejaculation. The licensed topical product is a spray
• Licensed anaesthetic creams exist for other purposes, and those uses are procedural, such as before needle insertion or minor surgery
• Absorption is enhanced on newly shaven skin, and the product information says the recommended dose, area and application time must be adhered to
• Anaesthetic cream should not be applied to open wounds, because of insufficient data on absorption

Does Numbing Cream Work for Premature Ejaculation?

Local anaesthetics can reduce penile sensitivity, and lidocaine and prilocaine formulations have been studied in premature ejaculation. But evidence for one particular product does not mean an unlicensed or cosmetic numbing cream has been shown to be safe or effective for this use.

What Is Established, and for What

The licensed topical treatment in the UK is a lidocaine and prilocaine cutaneous spray, indicated for primary premature ejaculation in adult men. In its trials, mean measured time rose from a baseline of 0.58 minutes to 3.17 minutes, against 0.56 to 0.94 minutes on placebo.

That evidence belongs to that spray, in that formulation, at that strength, applied that way. It does not transfer to a cream, and quoting it as though it does is the most common error on pages about this subject.

What Is Not Established for Creams

A product formulated for tattooing or another procedure may differ in strength, formulation, dosing instructions and intended site of application. None of those differences is minor, and none of them has been assessed for this use.

Why Tattoo Numbing Cream Is Particularly Concerning

This deserves the bluntest answer on the page. Do not do this.

Why the Site of Application Changes Everything

The genital area absorbs differently from areas such as the forearm, and some genital surfaces are mucosal tissue. So a product and quantity intended for another body site cannot simply be transferred to this one.

The Shaving Problem

The licensed product information for anaesthetic cream states that, because absorption is potentially enhanced on newly shaven skin, it is important to adhere to the recommended dose, area and time of application.

That warning exists for the licensed use. Using a product outside its intended site and instructions adds further uncertainty on top of it.

Strength Is Not an Advantage Here

Products sold for tattoo preparation are often higher strength than licensed medical creams, and that is marketed as a benefit.

A higher concentration is not automatically safer or more effective for this purpose. What matters is the specific formulation, quantity, site and duration that have been evaluated for the intended use.

Start Your Free Assessment

The Safety Warnings That Come With Anaesthetic Creams

These come from licensed product information for a lidocaine and prilocaine cream in its actual licensed uses. They are the closest available guide to what these ingredients do, and they are not reassuring when read against unlicensed use.

A Blood Disorder Risk

Prilocaine can affect how blood carries oxygen, producing a condition called methaemoglobinaemia.

The product information records that people with glucose-6-phosphate dehydrogenase deficiency, or with hereditary or unexplained methaemoglobinaemia, are more susceptible to it.

G6PD deficiency is inherited. That is a genuine reason for an assessment rather than a self-directed experiment, because the risk factor is invisible until it matters.

Broken or Damaged Skin

Because of insufficient data on absorption, the product information states the cream should not be applied to open wounds, with leg ulcers as the only stated exception.

Broken or damaged skin may alter how much is absorbed, which is the reason for that instruction.

Contact With the Eye

Applied near the eyes, the product information warns it may cause eye irritation and chemical burns.

That matters here because of what happens after application. Hands, transfer, and an unthinking rub of the eye is a realistic sequence, and "chemical burns" is not a mild phrase.

Allergic Reaction

Anaesthetic creams are contraindicated in anyone hypersensitive to lidocaine, prilocaine, amide-type local anaesthetics or any of the other ingredients.

Signs to take seriously are a rash extending beyond the treated area, swelling, raised welts, itching away from the application site, difficulty breathing, or any swelling of the face, lips or throat. The last group needs emergency medical help rather than a note to mention later.

The Reaction People Mistake for Normal

Local redness, pallor, swelling or burning can occur with topical anaesthetics. A reaction that is extensive, worsening, or accompanied by facial swelling or breathing difficulty, needs prompt medical attention.

Common local effects and an allergic reaction are not the same thing, and the difference is largely about whether it stays where it was put. Anything spreading is worth attention.

What Numbing Does to Your Own Experience

Reduced sensation is not a side effect of this approach. It is the approach.

The intended effect and the unwanted effect are the same mechanism, differing only in degree and location. Too little may do nothing, while too much reduces sensation more than intended.

Erection Firmness

In the licensed spray trials, erectile difficulty was reported by 4.4% of men.

That figure belongs to the spray and should not be used to estimate the risk from an unlicensed cream. It does illustrate why excessive local anaesthesia can matter clinically.

If Erectile Difficulty Is Already Present

Guidance says erectile dysfunction should be treated before or at the same time as premature ejaculation.

Applying an anaesthetic to the area while an erectile difficulty sits unassessed works against the thing guidance says to address first. The available erectile dysfunction treatments are prescription-only, and that sequencing question belongs in an assessment.

Cream Compared With the Licensed Spray

The right column is not a premium version of the left. It is the same class of ingredient with the questions answered.

Why the Spray Form Matters

A spray delivers a measured amount. A cream squeezed from a tube does not, and the quantity is judged by feel.

That is why the licensed product takes the form it does, and why the timing and removal steps in its product information mean something. Those steps exist because somebody measured what they achieved.

Products Designed for This Site

The UK licensed topical treatment for primary premature ejaculation is a lidocaine and prilocaine cutaneous spray.

Everything else is a product designed for another site, another purpose, or both. Some are licensed medicines being used outside their licence, which means they have not been assessed for this and none of their safety information applies to it. Some are cosmetic products that were never assessed as medicines at all.

Using a medicine outside its licensed indication means it has not been authorised for that use, so evidence, quantity and clinical judgement all have to be weighed for the individual rather than assumed from the licence.

Start Your Free Assessment

When a Numbing Product Is Not the Right Answer at All

Sometimes the honest answer is that this is the wrong tool. These are the situations where that is most likely:

• Erectile difficulty is present too. Guidance says treat that first, or at the same time
• Urinary symptoms, discomfort or bleeding are present. Infection such as prostatitis is named in guidance as something to treat first
• It started suddenly after a settled period. Something changed, and finding out what is more productive than numbing the result
• Anxiety is the dominant feature. Reducing sensation does not address anticipation, and can worsen it by adding a new thing to monitor

Most of those share one feature. Something else is going on, and numbing the area treats the symptom while leaving the cause in place. That is worth saying plainly, because reaching for a cream is often an attempt to avoid an assessment, and the assessment is what would find the item on this list that applies.

There is a second pattern worth naming. Numbing reduces information, and several of the situations above are ones where the information matters. Discomfort that would prompt a check gets muted. A change in erectile function that would be noticed gets harder to read. Anaesthetising the area does not only affect the outcome people are aiming at. It affects what they can tell about everything else happening there.

Getting This Looked at Properly

An assessment establishes whether the presentation matches what the licensed treatments cover, and what else needs dealing with first.

It covers when the difficulty began and whether there was a settled period beforehand, whether erectile function has changed, urinary or prostate symptoms, every current medicine, any reaction either person has had to a local anaesthetic including at the dentist, skin conditions affecting the area, and general health.

Medical Disclaimer

This page provides general information about anaesthetic products and premature ejaculation. It does not provide application instructions for any product, licensed or otherwise, and it is not a diagnosis. Treatment suitability depends on an individual clinical assessment.

Explore PE Treatment Options